Walley, Alexander Y.

Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study

Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018) · Annals of Internal Medicine

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 1,076

Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis

Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013) · BMJ

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 999

Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population

Morgan, J. R., Schackman, B. R., Leff, J. A., Linas, B. P., & Walley, A. Y. (2018) · Journal of Substance Abuse Treatment

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 332

Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts

Schiff, D. M., Nielsen, T., Terplan, M., Hood, M., Bernson, D., Diop, H., Bharel, M., Wilens, T. E., LaRochelle, M., Walley, A. Y., et al. (2018) · Obstetrics & Gynecology

Opioid Use Disorder TreatmentPrenatal Substance Exposure Effects

Cited by 327

Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose

Doe-Simkins, M., Walley, A. Y., Epstein, A., & Moyer, P. (2009) · American Journal of Public Health

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 250

Touchpoints—opportunities to predict and prevent opioid overdose: a cohort study.

Larochelle, M. R., Bernstein, R., Bernson, D., Land, T., Stopka, T. J., Rose, A. J., Bharel, M., Liebschutz, J. M., & Walley, A. Y. (2019) · Drug and Alcohol Dependence

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 189

Estimated prevalence of opioid use disorder in Massachusetts, 2011–2015: a capture–recapture analysis

Barocas, J. A., White, L. F., Wang, J., Walley, A. Y., LaRochelle, M. R., Bernson, D., Land, T., Morgan, J. R., Samet, J. H., & Linas, B. P. (2018) · American Journal of Public Health

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 164

Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort

Morgan, J. R., Schackman, B. R., Weinstein, Z. M., Walley, A. Y., & Linas, B. P. (2019) · Drug and Alcohol Dependence

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 159

Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study

Irvine, M. A., Oller, D., Boggis, J., Bishop, B., Coombs, D., Wheeler, E., Doe-Simkins, M., Walley, A. Y., Marshall, B. D. L., Bratberg, J., et al. (2022) · The Lancet Public Health

Opioid Use Disorder TreatmentHIV, Drug Use, Sexual Risk

Cited by 127

Opioid overdose prevention with intranasal naloxone among people who take methadone

Walley, A. Y., Doe-Simkins, M., Quinn, E., Pierce, C., Xuan, Z., & Ozonoff, A. (2013) · Journal of Substance Abuse Treatment

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 107

Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine

Park, T. W., Larochelle, M. R., Saitz, R., Wang, N., Bernson, D., & Walley, A. Y. (2020) · Addiction

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 78

Projected estimates of opioid mortality after community-level interventions.

Linas, B. P., Savinkina, A., Madushani, R. W. M. A., Wang, J., Eftekhari Yazdi, G., Chatterjee, A., Walley, A. Y., Morgan, J. R., Epstein, R. L., Assoumou, S. A., et al. (2021) · JAMA Network Open

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 72

Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort.

Morgan, J. R., Walley, A. Y., Murphy, S. M., Chatterjee, A., Hadland, S. E., Barocas, J., Linas, B. P., & Assoumou, S. A. (2021) · Drug and Alcohol Dependence

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 67

HERMITAGE —a randomized controlled trial to reduce sexually transmitted infections and HIV risk behaviors among HIV ‐infected Russian drinkers

Samet, J. H., Raj, A., Cheng, D. M., Blokhina, E., Bridden, C., Chaisson, C. E., Walley, A. Y., Palfai, T. P., Quinn, E. K., Zvartau, E., et al. (2015) · Addiction

HIV, Drug Use, Sexual RiskHIV/AIDS Research and Interventions

Cited by 33

Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design

Morgan, J. R., Quinn, E. K., Chaisson, C. E., Ciemins, E., Stempniewicz, N., White, L. F., Linas, B. P., Walley, A. Y., & LaRochelle, M. R. (2022) · Medical Care

Opioid Use Disorder TreatmentHealthcare Policy and Management

Cited by 30

A call for compassionate opioid overdose response

Russell, E., Hawk, M., Neale, J., Bennett, A. S., Davis, C., Hill, L. G., Winograd, R., Kestner, L., Lieberman, A., Bell, A., et al. (2024) · International Journal of Drug Policy

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 28

Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island

Zang, X., Bessey, S. E., Krieger, M. S., Hallowell, B. D., Koziol, J. A., Nolen, S., Behrends, C. N., Murphy, S. M., Walley, A. Y., Linas, B. P., et al. (2022) · JAMA Network Open

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 26

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder

Flam-Ross, J. M., Marsh, E., Weitz, M., Savinkina, A., Schackman, B. R., Wang, J., Madushani, R. W. M. A., Morgan, J. R., Barocas, J. A., Walley, A. Y., et al. (2023) · JAMA Network Open

Opioid Use Disorder TreatmentHealth Systems, Economic Evaluations, Quality of Life

Cited by 21

Federal Policymakers Should Urgently and Greatly Expand Naloxone Access

Jawa, R., Murray, S., Tori, M., Bratberg, J., & Walley, A. (2022) · American Journal of Public Health

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 10

[Commentary] CAN ONE BE AN EXPERT IN ADDICTION MEDICINE WITHOUT EXPERTISE IN PAIN MANAGEMENT?

SAMET, J. H., & WALLEY, A. Y. (2008) · Addiction

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 4